Nichol, who also served as vice president, controller and principal accounting officer at Zimmer Biomet, is now a VP and controller at Minnetonka, Minnesota-based Cargill.
Her departure was among the many notable medtech executive moves of 2021, and her destination wasn’t clear until recently.
Nichol left Zimmer Biomet in November after two years with the Warsaw, Indiana-based medical device company, which she joined in 2019 after serving as SVP, controller and chief accounting officer at pharma giant Endo International.
Zimmer Biomet did not name Nichol’s new employer when announcing her plans to leave, but a non-compete signed in 2019 meant she would likely exit the medtech industry (if the agreement is still in effect).
Zimmer Biomet is one of the 20 largest medtech companies in the world, with more than $7 billion in annual revenue and around 20,000 employees.
Cargill, a privately-held agribusiness firm with about 155,000 employees, reported revenue of $134.4 billion in its most recent fiscal year. A Cargilll spokesperson confirmed Nichols joined the company in late November.
Zimmer Biomet tapped Derek Davis to serve as principal accounting officer and interim controller and chief accounting officer while the company searches for Nichol’s replacement.